This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://www.prnewswire.com/news-releases/harbour-biomed-to-present-phase-ii-data-of-hbm4003-and-tislelizumab-combination-in-mss-metastatic-colorectal-cancer-at-esmo-2025-302516726.html?tc=eml_cleartime